A phase III trial for locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy versus chemotherapy alone
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Docetaxel; Filgrastim; Fluorouracil; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 02 Jul 2013 Biomarkers information updated
- 08 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 24 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.